These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3824229)

  • 21. [The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].
    Sorrentino GC; Caffari B; Vanacore N; Maggini M; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):63-8. PubMed ID: 16037652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
    Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
    Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the treatment of Alzheimer's disease.
    J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644
    [No Abstract]   [Full Text] [Related]  

  • 26. Donepezil in severe Alzheimer's disease.
    Winblad B
    Am J Alzheimers Dis Other Demen; 2009; 24(3):185-92. PubMed ID: 19246572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of treatment with acetyl-cholinesterase inhibitors on psychopathological symptoms in Alzheimer's disease].
    Rösler M; Frey U
    Fortschr Neurol Psychiatr; 2002 Feb; 70(2):78-83. PubMed ID: 11823923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological assessment of cognitive function in chronic alcohol-dependent patients and patients with Alzheimer's disease.
    Liappas I; Theotoka I; Kapaki E; Ilias I; Paraskevas GP; Soldatos CR
    In Vivo; 2007; 21(6):1115-8. PubMed ID: 18210766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of Alzheimer's disease.
    Grossberg GT
    J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differential diagnosis of Alzheimer's disease].
    Pasquier F
    Rev Prat; 1998 Nov; 48(17):1906-11. PubMed ID: 9854393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic drug studies in dementia and depression.
    Newhouse PA
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.
    Jorm AF
    Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic treatments for Alzheimer's disease.
    Roberts F; Lazareno S
    Biochem Soc Trans; 1989 Feb; 17(1):76-9. PubMed ID: 2653922
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of Alzheimer's disease: hopes and reality.
    Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic approaches to the treatment of Alzheimer's disease.
    Hollander E; Mohs RC; Davis KL
    Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861
    [No Abstract]   [Full Text] [Related]  

  • 38. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
    Byrne EJ; Arie T
    BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological replacement of cholinergic function in Alzheimer disease.
    Giacobini E
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():412A-413A. PubMed ID: 1498895
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical drug trials in Alzheimer's disease.
    Crook T
    Ann N Y Acad Sci; 1985; 444():428-36. PubMed ID: 3893271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.